Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers
Clinical trial NCT04666012 · COMPLETED
Trial details
- NCT number
- NCT04666012
- Sponsor
- Cellid Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2021-07-09
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.